Market Tracker

06/23 5:16pm ET

Alkermes Plc (NASDAQ:ALKS)

58.47
Delayed Data
As of Jun 23
 -0.21 / -0.36%
Today’s Change
39.65
Today|||52-Week Range
63.40
+5.20%
Year-to-Date

Today’s Trading

Previous close58.68
Today’s open58.81
Day’s range57.55 - 58.81
Volume992,352
Average volume (3 months)880,548
Market cap$9.0B
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+52.97%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+18.68%
P/E ratioNM
Price/Sales11.29
Price/Book7.37

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-1.51-2.39%
JAZZJazz Pharmaceuticals...-0.68-0.43%
TSROTESARO Inc-3.05-2.04%
ALNYAlnylam Pharmaceutic...+1.25+1.49%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$745.7M
Annual profit (last year)-$208.4M
Net profit margin-27.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts